Subscribe
MENU
Home
Litigation Tracker
BPCIA Litigations
Vaccine Patent Litigation
PTAB Tracker
Biosimilar PTAB Tracker
Vaccine Patent PTAB Tracker
FDA Approvals
Editors
Publications
Big Molecule Watch
BREAKING NEWS: D. Ct. Rules BPCIA 180-day Notice is Mandatory for Apotex’s pegfilgrastim product, Grants Preliminary Injunction in
Amgen v. Apotex
The order can be found
here
. Analysis to follow shortly.
Comments are closed.
The order can be found here. Analysis to follow shortly. 